Rachel Lenington

Insider Reports History

Location
Bothell, WA
Signature
/s/ Mark Worthington, Attorney-in-Fact for Rachel Lenington
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rachel Lenington:

Company Role Class Num Shares Value Price $ Report Date Ownership
Athira Pharma, Inc. COO and CDO Common Stock 20,870 $11,812 $0.5660 05 Sep 2024 Direct
Athira Pharma, Inc. COO and CDO Stock Option (Right to Buy) 300,000 14 Feb 2024 Direct

Insider Reports Filed by Rachel Lenington

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATHA Athira Pharma, Inc. 03 Sep 2024 2 -$1,429 4 COO and CDO 05 Sep 2024, 19:50
ATHA Athira Pharma, Inc. 14 Feb 2024 1 $0 4 COO AND CDO 16 Feb 2024, 16:46
ATHA Athira Pharma, Inc. 04 Jan 2024 2 -$7,019 4/A COO AND CDO 16 Feb 2024, 16:40
ATHA Athira Pharma, Inc. 04 Jan 2024 2 -$7,019 4 Chief Operating Officer 08 Jan 2024, 16:35
ATHA Athira Pharma, Inc. 19 Jan 2023 1 $0 4 Chief Operating Officer 23 Jan 2023, 16:45
ATHA Athira Pharma, Inc. 22 Jun 2022 2 -$11,279 4 Chief Operating Officer 24 Jun 2022, 19:50
ATHA Athira Pharma, Inc. 18 Jan 2022 1 $0 4 Chief Operating Officer 20 Jan 2022, 16:31
ATHA Athira Pharma, Inc. 03 Nov 2021 1 $0 4 Chief Operating Officer 05 Nov 2021, 17:02
ATHA Athira Pharma, Inc. 14 Jun 2021 0 $0 3 Chief Technology Officer 14 Jun 2021, 16:58